BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/31/2024 7:20:09 AM | Browse: 59 | Download: 292
 |
Received |
|
2023-12-18 10:21 |
|
Peer-Review Started |
|
2023-12-18 10:21 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-13 19:17 |
|
Revised |
|
2024-05-02 11:21 |
|
Second Decision |
|
2024-06-06 02:51 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-07 09:33 |
|
Articles in Press |
|
2024-06-07 09:33 |
|
Publication Fee Transferred |
|
2024-06-11 12:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-17 14:23 |
|
Publish the Manuscript Online |
|
2024-07-31 07:20 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Observational Study |
| Article Title |
Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Giorgia Rizza, Kyriaki Glynou and Masha Eletskaya |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Masha Eletskaya, MSc, Director, Director, N/A, Lumanity Insight (Cello Health Insight), Great Suffolk Yard, 2nd Floor, 131 Great Suffolk Street, London SE1 1PP, United Kingdom. masha.eletskaya@lumanity.com |
| Key Words |
Hepatitis B immunoglobulin; Liver transplantation; Subcutaneous; Intramuscular; Intravenous; Patient satisfaction |
| Core Tip |
Hepatitis B immunoglobulin (HBIG) combined with a potent nucleos(t)ide analog is recommended in patients undergoing liver transplantation for hepatitis B virus-associated disease. A survey was conducted to determine patients’ thoughts about three forms of HBIG treatment administration - subcutaneous (SC), intramuscular, and intravenous. Regarding current treatment, SC HBIG had the least negative impact on emotional well-being and social life, was most convenient, easiest to administer and least painful. Considering hypothetical HBIG products, SC was preferred over intramuscular and intravenous for ease of administration, convenience, and pain. For these patients, the most important considerations were ease of use, frequency, duration, and side effects. |
| Publish Date |
2024-07-31 07:20 |
| Citation |
<p>Rizza G, Glynou K, Eletskaya M. Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey. <i>World J Transplant</i> 2024; 14(3): 90949</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v14/i3/90949.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v14.i3.90949 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
